In this study, we have shown that in breast cancer cells, regulation of PRLR gene expression at the transcriptional level by its own ligand, independent of E2, can take place with the essential participation of the JAK2/STAT5 and mitogen-activated protein kinase (MAPK) signaling pathways. The gene discussed is PRLR; the disease is breast carcinoma.